Alzheimer’s is a mind-body malaise that experts say can take up to 20 years to run its fearsome course—like having a sliver ...

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

Prehospital hypoxia, hypotension, and hypocarbia each were associated with poor outcomes after traumatic brain injury, ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...

In obesity, Lilly removed a dual amylin calcitonin receptor agonist (DACRA) from its phase 1 pipeline. Lilly got into DACRAs ...

Alzheimer’s disease affects more than 30m people worldwide, mostly the elderly. After the age of 65, the chance of developing ...

A member of the European Parliament from The Left group was accused of making a “disrespectful” joke about dementia by ...

Eli Lilly & Company Chairman and CEO Dave Ricks sheds light on growth and success, the increase in weight loss drug ...

Older adults with Alzheimer’s disease and related dementias faced a greater risk for hospitalization after being continuously ...

New research from Edith Cowan University (ECU) has shown that diet could influence the risk of both depression and ...

Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.